338 related articles for article (PubMed ID: 19408409)
1. Cancer care expands to include genetic testing.
Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):4-5. PubMed ID: 19408409
[No Abstract] [Full Text] [Related]
2. Genetic testing in cancer therapeutics.
Ezzeldin HH; Diasio RB
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
[No Abstract] [Full Text] [Related]
3. [Future cancer care challenges the health care].
Olofsson S
Lakartidningen; 2010 Apr 21-27; 107(16):1065. PubMed ID: 20476702
[No Abstract] [Full Text] [Related]
4. A radical rethinking of treatment. The aim is to make cancer curable or a manageable chronic disease.
Hobson K
US News World Rep; 2008 Nov 3-10; 145(10):48-50, 53. PubMed ID: 18998442
[No Abstract] [Full Text] [Related]
5. X chemotherapy, myth and realities.
Thomas M; Pavithran K
J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871
[TBL] [Abstract][Full Text] [Related]
6. Personalized cancer therapy gets closer.
Hayden EC
Nature; 2009 Mar; 458(7235):131-2. PubMed ID: 19279593
[No Abstract] [Full Text] [Related]
7. [Molecular medicine--personalized medicine. Principles and state-of-the-art].
Blum HE
Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1568-72. PubMed ID: 15965865
[No Abstract] [Full Text] [Related]
8. [Great risk of future problems for Swedish cancer care].
Bergh J; Wilking N
Lakartidningen; 2010 Oct 6-12; 107(40):2376-7. PubMed ID: 21140568
[No Abstract] [Full Text] [Related]
9. Therapeutic drug monitoring in oncology: does it have a future?
McMahon G; O'Connor R
Bioanalysis; 2009 Jun; 1(3):507-11. PubMed ID: 21083145
[No Abstract] [Full Text] [Related]
10. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
Beer PA; Cooke SL; Chang DK; Biankin AV
Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210
[No Abstract] [Full Text] [Related]
11. [What is happening within cancer drug therapy? The Danish Society of Medical Oncology].
Dansk Selskab for Medicinsk Onkologi's bestyrelse (DMO)
Ugeskr Laeger; 2001 Mar; 163(12):1708. PubMed ID: 11284408
[No Abstract] [Full Text] [Related]
12. Biomarkers and oncology: the path forward to a learning health system.
Yu PP; Hoffman MA; Hayes DF
Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
[No Abstract] [Full Text] [Related]
13. Integrated patient and tumor genetic testing for individualized cancer therapy.
Hertz DL; McLeod HL
Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
[TBL] [Abstract][Full Text] [Related]
14. Precision oncology: an overview.
Garraway LA; Verweij J; Ballman KV
J Clin Oncol; 2013 May; 31(15):1803-5. PubMed ID: 23589545
[No Abstract] [Full Text] [Related]
15. Genomic testing: a struggle for oncologists.
Hede K
J Natl Cancer Inst; 2014 Jun; 106(6):dju172. PubMed ID: 24907388
[No Abstract] [Full Text] [Related]
16. "Therapeutic intent" in phase 1 oncology trials: a justifiable objective.
Markman M
Arch Intern Med; 2006 Jul; 166(14):1446-8. PubMed ID: 16864753
[No Abstract] [Full Text] [Related]
17. Results of cancer care quality study lead to cautious optimism, caveats.
Christensen D
J Natl Cancer Inst; 2004 Aug; 96(15):1124-5. PubMed ID: 15292381
[No Abstract] [Full Text] [Related]
18. Cancer research. Looking for a target on every tumor.
Kaiser J
Science; 2009 Oct; 326(5950):218-20. PubMed ID: 19815749
[No Abstract] [Full Text] [Related]
19. [The current potentials and outlook for drug therapy in oncology].
Gershanovich ML; Borisov VI; Sidorenko IuS; Tiuliandin SA; Gorbunova VA
Vopr Onkol; 1995; 41(2):116-24. PubMed ID: 7483406
[No Abstract] [Full Text] [Related]
20. Oncologists have lost a battle against cancer; biomedicine has not lost the war.
Mathé G
Biomed Pharmacother; 1986; 40(10):370-1. PubMed ID: 3580504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
